Time
|
HALL A - Plenary Room
(TERPSICHORE A&B)
|
Nursing Day II
|
HALL C - Breakout Room
(HESPERIDES)
|
HALL B - Breakout Room
(TERPSICHORE C)
|
08.00 - 09.40
|
Moderators: O. Brosjo, R. Capanna, S. Dijksta
Free Communications Session VIIA:
Allografts – Megaprostheses
FC 076 - FC 085 (See details)
FC-076 • The mechanical effect of extracorporeal irradiation on bone
S. Gupta, D. Cafferky, F. Cowie, P. Riches, I. Anthony, A. Mahendra
FC-077 • Periprosthetic fractures after massive knee and hip prosthesis: a retrospective analysis of 21 cases
N. Barut, P. Anract, A. Babinet, D. Biau
FC-078 • Use of osteoarticular bone allografts in limb salvage reconstruction of the proximal tibia
L.C. Gomez, C. Soto, M. Maldonado, R. Sanchez
FC-079 • Joint sparing surgery using recycled tumor-bearing autograft for osteosarcoma
M. Miyagi, H. Katagiri, S. Hosaka, J. Wasa, H. Murata, M. Takahashi
FC-080 • Aseptic loosening of knee megaprosthesis: 22 years data analysys (the East-European Sarcoma Group)
A. Sokolovsky, M. Aliev, V. Sokolovsky, P. Sergeev, A. Sukhov
FC-081 • Long-term results of knee replacement with MUTARS® modular endoprostheses in treatment of primary tumors
M. Bus, M. van de Sande, S. Dijkstra
FC-082 • Uni- or bipolar proximal femoral endoprostheses following tumour reconstruction: are acetabular resurfacings necessary?
J. Stevenson, V. Kumar, G. Cribb, P. Cool
FC-083 • Endoprosthetic failure after resection of primary or secondary bone tumors in the proximal humerus and reconstruction with the MUTARS™ system – A systematic analysis
D. Andreou, J.N. Broking, G. Gosheger, J. Wilhelmy, M.-P. Henrichs, M. Nottrott, J. Hardes, A. Streitburger
FC-084 • Intercalary allograft reconstruction after resection of primary bone tumors
L. Pazourek, M. Mahdal, T. Toma, P. Janjek, J. Cerny, S. Ondrusek
FC-085 • Results of massive osteochondral allograft reconstruction for tumors at the knee area
T. Tomas, P. Janjek, J. Cerny, S. Ondrjek, L. Pazourek, M. Mahdal
|
(08.00-09.00)
Moderators: P. Arvaniti, N. Leijerzapf, R. Leoni
Nurse Programme Session III:
Free Communications
NS 05 - NS 10 (See details)
NS-06 • Retrospective analysis of the management of the high-risk bleeding sarcoma patient with bleeding-preventing intravascular device
R. Leoni, R. Martinelli, A. Cipriano, F. Salassa, M. De Bergolis, G. Bax, M. Garofalo, N. Albanese, P. Benotto
NS-07 • Physical exercise in patients with osteosarcoma or Ewing sarcoma in the lower extremity: a literature study
D.C.G. Boonman, I. van Dooren, K.A. de Groot, S.C. Scheurwater, J.C. Boiten, H.M. Vermeulen, W.P. Bekkering
NS-08 • Quality of life after malignant bone cancer surgery; a long term follow-up study
W.P. Bekkering, J.C. Egmond-van Dam, J.A.M. Bramer, A. Beishuizen, M. Fiocco, P.D.S. Dijkstra
NS-09 • Intravenous chemotherapy at home
P. Arvaniti, D. Venetis, T. Theodoropoulos, T. Pylios
NS-10 • Computer use, staff hygiene and infections in Orthopedic Clinic:/em>
D. Petroudi
|
(08.00-09.00)
Moderators: G. Agrogiannis, L. Campanacci, J. Wunder
Free Communications Session VIIIA:
Soft Tissue Tumors
FC 097 - FC 106 (See details)
FC-097 • Soft tissue sarcoma abutting the bone, does it carry a worse prognosis, and what surgery is the most appropriate?
A. Shehadeh
FC-098 • Marginal resection for lipomas and atypical lipomatous tumors of the extremities: retrospective comparison with histology and MDM2 gene amplification
C. Errani, S. Cocchi, N. Ali, M. Chehrassan, A. Righi, D. Donati
FC-099 • What is the significance of a fungating soft tissue sarcoma?
R. Grimer, M. Parry, H. Wafa, S. Sugath
FC-100 • The “two-week wait" referral system: how predictive of malignancy are the worrying features for soft tissue sarcomas?
M. Smolle, A. Leithner, R. Grimer
FC-101 • Aggressive primary synovial chondromatosis of the hip
W.J. Anderson, M. Vlychou, Y. Inagaki, D. Whitwell, C.L.M.H. Gibbons, N.A. Athanasou
FC-102 • Re-excision of residual sarcomas ("second-look surgery"): analysis of our results
A. Peiro, I. Gracia, L. Trullols, A. Garcia, M. Angelica, O. Buezo
FC-103 • Extraskeletal chondrosarcomas: how to identify bad prognostic factors for local recurrence and survival?
U. Albertini, M. Boffano, S. Marone, E. Boux, G. Grignani, A. Linari, A. Comandone, R. Piana
FC-104 • IMRT delivery of preoperative high dose radiotherapy with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: a feasibility study
S. El-Sayed, K. Carty
FC-105 • Myxofibrosarcoma: a particularly difficult-to-treat soft tissue sarcoma – Considerations from a series of 85 patients
G. Scoccianti, G. Beltrami, A. Franchi, F. Frenos, M. Faccio, R. Capanna
FC-106 • Sarcoma of the foot: changes in amputation rate over one decade
O. Tendero, I. Felipe-Abrio, P. Sancho, J. Martin-Broto, I. Monge, D. Salinas, R. Ramos, I. Alastuey, P. Luna, J. Estrada, L. Muntaner, A. Ballesteros
|
09.40 - 11.30
|
Moderators: D. Donati, M. Gebhardt, J. De Las Heras
Free Communications Session VIIB:
Allografts – Megaprostheses
FC 086 - FC 096 (See details)
FC-086 • Proximal tibia reconstruction after primary bone tumor resections: endoprosthetic replacement versus osteoarticular allograft
J. Albergo, L. Muscolo, R. Grimer, L. Gaston Czar, L. Aponte-Tinao, L. Jeys, G. Farfalli, S. Carter, M. Ayerza, R. Tillman, A. Abudu
FC-087 • Silver ions levels in body fluids and clinical results in silver-coated megaprostheses: a 1 to 4 years follow-up
G. Scoccianti, G. Beltrami, M. Ippolito, F. Frenos, A. D'Arienzo, R. Capanna
FC-088 • The vascularized fibular graft for limb salvage after bone tumor surgery: a multicentre study
Oxford Sarcoma Service (OSS), Dutch Orthopaedic Tumour Society (DOTS)
FC-089 • Is silver worthwhile on all endoprostheses?
R. Grimer, M. Parry, L. Jeys
FC-090 • Biological extramedullary fixation in limb salvage surgery with HA collars
I. Papakostas, G. Alexiadis, S. Sarafopoulos, C. Tzouros, S. Dara, T. Kormas
FC-091 • Allografts in children and adolescents after resection of malignant bone tumors
A. Vaquero-Picado, E. Ferrer Santacreu, J. De Las Heras Sotos
FC-092 • Use of tricortical autologous graft from iliac crest reconstruction of long bone defects after block resection in tumor indications
J. Lesensky, Z. Matejovsky
FC-093 • Massive intercalary allograft reconstruction after long bone tumor resection
M. Bergovec, M. Smerdelj, V. Radočaj, K. Barbaric, A. Bonevski
FC-094 • Are we aggressive in performing two-stage reimplantation for periprosthetic infection after tumor resection around knee?
S. Bindiganavile, M. Depaolis, C. Romagnoli, M. Romantini, D.M. Donati
FC-095 • Infected tumor prostheses: a review of 125 cases from two institutions
E. Pala, P. Ruggieri, A.F. Mavrogenis, A. Angelini, G. Trovarelli, B. Haddad, C. Vottis, T. Calabrò, V. Igoumenou, P.J. Papagelopoulos
FC-096 • Massive resection of diaphyseal primary bone sarcomas and reconstruction using recycled pasteurized tumor segment
A. Rafalla
|
(09.40-10.10)
Moderators: V. Kontogeorgakos, I. Tseka
Nurse Programme Session IV: Lectures
Rehabilitation in orthopaedic oncology patients
Evanthia Mitsiokapa
Wound problems in orthopaedic oncology patients
Vasileios Sakellariou
(10:10-11:30)
Moderators: E. Patiraki, S. Katsaragakis
Round Table: Enhancing quality in Palliative care. A nursing perspective
Assessment problems and needs for Palliative
Care of adult hospitalized patients with
advanced cancer
D. Protogiros
Individualized care and quality of care of hospitalized cancer patients in Greece
C. Adam
The concept of good death in Palliative Care
ME. Galanaki
Exploring dignity in end of life care
S. Sgourou
Home Palliative Care outcomes of Greek patients with cancer
S. Katsaragakis
|
(09.40-11.20)
Moderators: J. Bickels, Z. Matejovsky, J. Panayiotidis
Free Communications Session VIIIB:
Soft Tissue Tumors
FC 107 - FC 116 (See details)
FC-107 • Extra-abdominal desmoid tumor: prognostic factors and clinical outcome in a surgical series
M.W. Joo, Y.-K. Kang, Y.-G. Chung, W.-J. Bahk
FC-108 • The impact of “extended surgical procedures” on the outcome of soft tissue sarcomas
C. Stihsen, C. Novak, J. Panotopoulos, R. Windhager, P. Funovics, Philipp
FC-109 • Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: analysis of 2626 surgically treated patients from the Scandinavian Sarcoma Group register
P. Tsagozis, H. Bauer, E. Styring, C. Trovik, O. Zaikova, O. Brosjo
FC-110 • Outcome following resection of synovial sarcoma – Analysis of prognostic factors with a minimal follow up of 5 years
U. Lenze, E. Hylla, F. Pohlig, F. Lenze, J. Schauwecker, R. Gradinger, H. Rechl, R. von Eisenhart-Rothe
FC-111 • Atypical lipomatous tumor and liposarcoma of the musculoskeletal system – Outcome analysis with a minimal follow up of 5 years
U. Lenze, J. Breitenbach, F. Pohlig, F. Lenze, C. Knebel, A. Toepfer, H. Rechl, R. von Eisenhart-Rothe
FC-112 • Single institution experience of isolated limb perfusion with melphalan in treatment of advanced extremity melanoma and soft tissue sarcomas
N. Petrachenko, T. Kharatishvili, Y. Buydenok, B. Narkevich, D. Martynkov, A. Fedenko, M. Aliev
FC-113 • Soft tissue sarcomas in patients over 65 years old. Clinical outcomes of different subgroups from a regional centre in the UK
Z. Khan, C.F. Yiu, W. Wignadasan, C.J. Richards, C.P. Esler, S. Carvell, R.U. Ashford
FC-114 • 5-Aminolevulinic acid photoablation of fibrotic soft-tissue tumors
J. Bickels, Y. Gortzak, A. Sternheim, Y. Kollender
FC-115 • Extraabdominal desmoid tumors – From watchful waiting to extensive surgery: results of different treatment modalities in Switzerland
A.H. Krieg, C. Wirth, C. Kettelhack, D. Baumhoer, F. Klenke, K. Siebenrock, U. Exner, B. Bode, B. Fuchs, F. Hefti
FC-116 • Adjuvant radiotherapy in leiomyosarcomas and liposarcomas – Experience of a center
A. Branquinho, D. Macedo, A. Mansinho, I. Fernandes, D. López, F. Pina, J. Portela, H. Vasques, M. Jorge, L. Costa
|
11.30 - 12.00 |
Coffee Break
|
12.00 - 13.00 |
Moderator: F.H. Sim
Campanacci Lecture: Leaders-Mentors and the path for continuity
Luis Muscolo
|
|
|
13.00 - 14.00 |
Lunch Break |
14.00 - 15.00 |
Moderator: P.J. Papagelopoulos
Enneking Lecture: Advances in the Management of Soft Tissue Tumors
Franklin Sim |
|
|
15.00 - 15.30 |
Moderator: P. Rose
Lecture: Sacropelvic tumors and spinopelvic
reconstruction
Wei Guo
|
(15.00 - 17.00)
Moderators: J. Lesensky, H. Ozger, J. Panotopoulos
Free Communications Session IX:
Cartilaginous Tumors
FC 117 - FC 128 (See details)
FC-117 • Chondrosarcoma in children and adolescents – Are they different?
A. Puri, A. Gulia, R. Vishnu
FC-118 • Vectorization of hypoxia activated prodrugs to chondrosarcoma proteoglycans: evaluation and characterization of antitumoral activity
A. Voissiere, V. Weber, M.-M. Auplat, F. Degoul, J.-M. Chezal, F. Redini, E. Miot-Noirault, C. Peyrode
FC-119 • Surgical treatment of primary central conventional chondrosarcoma of pelvic bone: an evaluation of outcome in four European centers of orthopaedic oncology
M. Bus, D. Campanacci, A. Leithner, M. van de Sande, G. Caff, J. Mettelsiefen, R. Capanna, P.-U. Tunn, S. Dijkstra
FC-120 • Local recurrence following curettage and cementation of low-grade chondrosarcomas
M. Hiz, B. Gorgun, S. Kocak, S. Dervisoglu
FC-121 • Extended curettage followed by ethanol application and bone graft for grade 1 chondrosarcoma of the appendicular skeleton
M.W. Joo, Y.-G. Chung, Y.-K. Kang
FC-122 • Chondrosarcoma of the pelvis: a critical review of 58 consecutive patients from a single center cohort
C. Stihsen, S. Puchner, J. Panotopoulos, R. Schuh, R. Windhager, P. Funovics
FC-123 • Chondrosarcoma surveillance – The Stanmore experience
M. Brown, P. Gikas, J. Jagiello, W. Aston, J. Skinner, T. Briggs, R. Pollock
FC-124 • Chondrosarcoma of the pelvis a review of sixty five cases between 1996 and 2013
A. Salduz, G.A. Norambuena Morales, P.S. Rose, F.H. Sim, Franklin H.
FC-125 • Argon beam and high speed bur as adjuvants in the treatment of low grade cartilage tumors
M. Galli Serra, M.J. Portillo Franco, W.M. Parizzia
FC-126 • Chondrosarcoma of hand and feet – Review of 37 cases from single institution
J. Lesensky, Z. Matejovsky, I. Kofranek
FC-127 • Follow-up of untreated chondroid lesions in the long bones
I. van der Geest, C. Deckers, B. Schreuder
FC-128 • Surgery of pelvic chondrosarcomas: a review of 285 cases from two institutions
A. Angelini, A.F. Mavrogenis, E. Pala, G. Trovarelli, T. Calabrò, C. Vottis, P. Megaloikonomos, P. Papagelopoulos, P. Ruggieri
|
(15.00 - 17.00)
Moderators: R. Turcotte, P. Tsagozis, K. Tsanidis
Free Communications Session X:
Giant Cell Tumor of Bone
FC 129 - FC 140 (See details)
FC-129 • Giant cell tumor of bone in children and adolescents: a report of 10 cases
P. Arbelaez, F. Linares, J. Manrique, M. Fernadez
FC-130 • Clinical presentation and outcome of giant cell tumor of the pelvis and sacrum
G. Hoogzaad, J. Chan, L. Gaston, K. Reddy, S. Carter, L. Jeys, R. Grimer, S. Abudu
FC-131 • Denosumab – A new bullet in the armamentarium for giant cell tumor
A. Puri, A. Gulia, V. Verma
FC-132 • Sacral giant cell tumors – To operate or not to operate!
A. Puri, A. Gulia, M. Bhandari
FC-133 • Efficacy of Denosumab with special reference to its role in joint preservation as an adjuvant in the management of giant cell tumor of bone
F. Traub, B. Dickson, R. Mohankumar, M. Blackstein, A. Griffin, P. Ferguson, J. Wunder
FC-134 • Adjuvant zoledronic acid in high-risk giant cell tumor of bone – Preliminary results of a randomized phase II study
L. van der Heijden, S. Dijkstra, M. van de Sande, P. Jutte, H. Gelderblom, N. Hamdy, P. Hogendoorn, J. Kroep
FC-135 • Giant cell tumor of the distal radius: is resection better?
R. Turcotte, H. Sawan, P. Ferguson, J. Wunder, M. Isler, S. Mottard, J. Werier, H. Abdelbary
FC-136 • Is it possible to predict recurrence of giant cell tumor of bone – Our experience and dilemmas?
N. Lujic, J. Sopta, R. Kovacevic, R. Davidovic, S. Rajkovic, Z. Bascarevic, D. Ristic
FC-137 • Comparison of clinical results with bone allograft or PMMA after intralesional curettage for giant cell tumors of bone
P.F. Horstmann, P. Holmberg Jorgensen, W. Hettwer, B. Hauge Hansen, M. Mørk Petersen
FC-138 • Denosumab in giant cell tumor of bone: innovation or chimera?
G. Beltrami, G.G. Baldi, G. Scoccianti, A. D'Arienzo, F.R. Campo, F. Frenos, D.A. Campanacci, A. Franchi, R. Capanna
FC-139 • Clinical and pathological results of Denosumab in the treatment of giant cell tumor of the bone
M.A. Deveci, S. Paydayi, G. Gonlusen, C. Ozkan, O.S. Bicer, M. Tekin, I. Tan
FC-140 • Emerging role of Denosumab in the management of giant cell tumor of bone
W. Ebeid, M. Abdulla, R. Abdelmoneim, E. Saad, D. Ezzeldin
|
16.00 - 16.30 |
Moderator: J. Healey
Lecture: Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
Michelle Ghert
|
16.30 - 17.00
|
Coffee Break
|
17.00 - 19.30
|
Moderators: M. Manfrini, A. Taminiau, Ch. Zambakidis
Free Communications Session XI:
Pediatrics
FC 141 - FC 156 (See details)
FC-141 • Prevention of infectious complications in children with bone tumors after the arthroplasty
M. Rykov, A. Dzampaev, V. Polyakov
FC-142 • Limb salvage in skeletal immature patients: Japanese experience
T. Ozaki, T. Kunisada, K. Takeda, T. Fujiwara
FC-143 • Outcome of pelvic bone sarcomas in children under 16 years of age
M. Laitinen, M. Parry, J. Albergo, A. Abudu, S. Carter, R. Tillman, L. Jeys, R. Grimer
FC-144 • Long-term follow-up of functional outcome after malignant bone cancer surgery around the knee
J. van Egmond-van Dam, P. Bekkering, J. Bramer, A. Beishuizen, M. Fiocco, S. Dijkstra
FC-145 • First report of X-pand tumor prosthesis experience in Ukraine
O. Vyrva, R. Malik, V. Baev
FC-146 • Fibrous displasia of craniofacial area in children and adolescents
D. Rogozhin, D. Konovalov, M. Bolotin, A. Lopatin, I. Boulytcheva, V. Roshin, A. Talalaev, A. Kugushev
FC-147 • The spectrum of bone giant cell lesions in children and adolescents
D. Rogozhin, A. Kugushev, D. Konovalov, M. Bolotin, A. Lopatin, I. Boulytcheva, V. Roshin, A. Ektova, A. Kuzin, A. Talalaev
FC-148 • Early management of pathological fractures in the skeletally immature
L. Bayliss, A. Simpson, P. Monk, N. Athanasou, A. Wainwright, M. Gibbons, T. Theologis
FC-149 • Expandable prosthesis in reconstructing distal femoral defects following tumor resection: evaluation of a two-stage procedure
W. Ebeid, W. Abousenna
FC-150 • Bone sarcomas of the proximal femur in small children: the challenge of hip reconstruction in a growing patient
M. Manfrini, M. Colangeli, L. Campanacci, M. De Paolis, D. Donati
FC-151 • Non-invasive growing prostheses in children affected by malignant tumors of the knee: early results from a single institution
A. Daolio Primo, S. Bastoni, F.L. Giardina, A. Della Valle, M.S. Bartoli, C. Meazza, M. Massimino
FC-152 • Short term experience with the Xpand non-invasive expandable endoprosthesis
Y. Gortzak, J. Bickels, A. Sternheim, Y. Kollender, A. Nirkin, D. Levin, S. Dadia
FC-153 • Expandable prosthesis in children after bone tumour resection of the distal femur. The experience of the Rizzoli Institute
E.L. Staals, M. Colangeli, N. Ali, E. Sebastiani, D. Donati, M. Manfrini
FC-154 • Internal hemipelvectomy – Possibility of reconstruction in children and youth with primary malignant bone tumors
A. Szafranski, M. Rychłowska-Pruszynska, B. Pachuta, I. Malesza, T. Walenta
FC-155 • Expandable endoprosthesis in children and adolescents after malignant tumor resection – Own experience
A. Szafranski, M. Rychłowska-Pruszynska, B. Pachuta, I. Malesza, T. Walenta
FC-156 • Limb salvage surgery for primary malignant bone tumors in children younger than 5 years
M. Rychłowska-Pruszyńska, A. Szafrański, B. Pachuta, M. Karwacki, A. Raciborska
|
(17.00 - 19.10)
Moderators: D. Biau, F. Fazioli, A. Puri
Free Communications Session XII:
What’s New?
FC 157 - FC 169 (See details)
FC-157 • Evidence of a monoclonal origin of tenosynovial giant cell tumor
L.A. Holzer, A. Weinhaeusel, B. Liegl-Atzwanger, K. Trieb, O.A. Haas, A. Leithner
FC-158 • Post-surgery wound fluid stimulates ex vivo soft sarcoma re-growth
F. De Nigris, M. Gallo, M. Di Somma, G. Colella, F. Fazioli
FC-159 • Chemotherapy revived - intraarterial cisplatin-based chemotherapy in an osteosarcoma xenograft model
B. Robl, S. Botter, M. Arlt, B. Fuchs
FC-160 • Metilation of p14ARF and p16INK4a – A possible role in the pathogenesis of liposarcoma
J. Sopta, R. Davidovic, R. Kovacevic, D. Ristic, J. Bokun, A. Djordjevic, N. Lujic, G. Djuricic
FC-161 • EURAMOS-1: results from the randomised questions of the first European-American osteosarcoma study
J. Whelan, S. Bielack, S. Smeland, N. Marina, T. Butterfass-Bahloul, G. Jovic, M. Sydes, M. Bernstein
FC-162 • L-MTP-PE and zoledronic acid association in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer
F. Redini, K. Bitau, J. Taurelle, R. Guiho, J. Chesneau, J. Amiaud, N. Corradini, D. Heymann
FC-163 • Navigated joint sparing bone tumor resections
A. Sternheim, J. Wunder, A. Kashigar, M. Daly, J. Qiu, R. Weersink, H. Chan, D. Jaffray, J. Irish, P. Ferguson
FC-164 • Halofuginone inhibits primary tumor growth and lung metastasis development in osteosarcoma
A. Lamora, M. Mullard, J. Amiaud, R. Brion, D. Heymann, F. Redini, F. Verrecchia
FC-165 • Blocking TGF-beta signaling pathway inhibits the development of osteosarcoma lung metastases
A. Lamora, J. Talbot, J. Amiaud, G. Bougras, M.C. Le Deley, D. Heymann, F. Redini, F. Verrecchia
FC-166 • A prospective cohort study using computer assistance during resection of musculoskeletal tumors
P. Young, A. Mahendra
FC-167 • Mifamurtide (L-MTP-PE) in children with osteosarcoma: the Turkish experience
R. Kebudi, I. Ilhan, M. Kantar, F. Cakir, E. Guler, N. Olgun, T. Celkan
FC-168 • Identification of CD146 as a marker of tumor-propagating cells in human sarcomas leads to novel treatment opportunities
J. Wunder, J. Tang Yuning, Q. Wei, H. Whetstone, L. Ailles, G. Bader, B. Alman
FC-169 • PET response criteria (PERCIST) predict progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma
W.P. Fendler, M. Lehmann, A. Todica, K. Herrmann, T. Knösel, M.K. Angele, H.R. Dürr, J. Rauch, S. Abdel-Rahman, R.D. Issels, P. Bartenstein, C.C. Cyran, M. Hacker, L. Lindner
|
Moderators: A.F. Mavrogenis, I. Papanastasiou, M. Hiz
Free Communications Session XIII:
Miscellaneous – Quality of Life
FC 170 - FC 181 (See details)
FC-170 • Validation of EQ-5D in patients treated for extremity sarcoma
A. Suokas, G. Stephens, L. Gosling, R. Grimer
FC-171 • Proton beam radiotherapy for unresectable bone and soft tissue sarcoma
H. Katagiri, S. Murayama, T. Nishiumura, M. Takahashi, H. Murata, J. Wasa, S. Hosaka, M. Miyagi
FC-172 • Clinical and radiological presentation of osteoid osteoma of the foot
M. Bergovec, M.M. Gilg, L. Repsa, M. Smerdelj, A. Leithner
FC-173 • Laboratory based measurement of physical functioning after treatment for sarcoma using a triaxial accelerometer – A feasibility study
S. Furtado, A. Godfrey, B. Galna, C. Tseminidis, N. Rutter, T. Ploetz, D. Jameson, L. Rochester, C. Gerrand
FC-174 • Evaluating physical activity in the community after sarcoma treatment using triaxial accelerometry. A new paradigm for outcome assessment?
S. Furtado, C. Gerrand, A. Godfrey, B. Galna, C. Tseminidis, N. Rutter, A. Hickey, D. Jameson, T. Ploetz, L. Rochester
FC-175 • Service redesign for tertiary sarcoma referral service
P. Young, D. Wallace, H. Wafa, M. Halai, H. Findlay, A. Mahendra
FC-176 • Transhumeral amputees treated with the OPRA implant system – Results and future possibilities with bionic limbs integrated to the bone
O. Berlin, G. Tsikandylakis, R. Branemark
FC-177 • Oncologic and functional result after treatment of patients with fibular osteosarcoma
P. Ruggieri, G. Trovarelli, E. Pala, G.I. Piraino, T. Calabrò, B. Haddad, A.F. Mavrogenis, A. Angelini
FC-178 • Outcome of primary leiomyosarcoma of bone – Current evidence and a report of 21 cases from two musculoskeletal tumor centers
M. Willegger, S. Bronimann, R. Schuh, R. Nakayama, H. Morioka, R. Windhager, J. Panotopoulos, P.T. Funovics
FC-179 • Can feed-back based gait training in tumor arthroplasty influence motion sequence?
B. Lehner, R. Bitsch, R. Rupp, C. Schuld
FC-180 • Can neoadjuvant radiotherapy facilitate a safer resection and limb sparing surgery in the treatment of osteosarcoma?
H. Ozger, F. Agaoglu, M. Sungur, B. Alpan, N. Valiyev
FC-181 • Stereotactic Body Radiotherapy (SBRT) for the treatment of renal cell carcinoma metastases with oligometastatic disease
S.E. Wozniak, S. Horasak, A. Aboulafia
|
19.30 - 20.00 |
Awards / Closing Remarks
Presentation of EMSOS 2016
(Nantes, France) |
|
|